Multimodal Ultrasound in Peripheral Neuropathy

February 7, 2025 updated by: Abdullah Galal, Assiut University

Role of Multimodal Ultrasonography in Evaluation of Peripheral Neuropathy

This study will enforce the role of ultrasound in early diagnosis and screening on peripheral neuropathy in comparison with other modalities.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Each case will undergo informed Written consent and will be told the aim of the study including benefits, no harm from this procedure to the participants.

Study Type

Observational

Enrollment (Estimated)

50

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients with clinical data of peripheral neuropathy who can cooperate to do the procedure not mentally retarded and healthy skin texture .

Description

Inclusion Criteria:

  • patients with clinical symptoms of peripheral neuropathy

Exclusion Criteria:

  • patients with unhealthy tissue texture to put on probe

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Role of multimodal ultrasonography in evaluation of peripheral neuropathy
Time Frame: 3 years
Enforce the role of ultrasound in screening and early detection of nerve affection in peripheral neuropathy in comparison with the traditional modalities as nerve biopsy and nerve conduction
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2025

Primary Completion (Estimated)

December 15, 2025

Study Completion (Estimated)

January 15, 2026

Study Registration Dates

First Submitted

November 22, 2024

First Submitted That Met QC Criteria

November 28, 2024

First Posted (Actual)

December 2, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 7, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Ultrasound in neuropathy

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Neuropathy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe